Your browser doesn't support javascript.
loading
The dihydrofolate reductase 19-bp deletion modifies the beneficial effect of B-vitamin therapy in mild cognitive impairment: pooled study of two randomized placebo-controlled trials.
Wu, Yuanyuan; Smith, A David; Bastani, Nasser E; Refsum, Helga; Kwok, Timothy.
Afiliación
  • Wu Y; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.
  • Smith AD; Oxford Project to Investigate Memory and Ageing (OPTIMA), Department of Pharmacology, University of Oxford, Oxford OX1 2JD, UK.
  • Bastani NE; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, NO-0316 Oslo, Norway.
  • Refsum H; Oxford Project to Investigate Memory and Ageing (OPTIMA), Department of Pharmacology, University of Oxford, Oxford OX1 2JD, UK.
  • Kwok T; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, NO-0316 Oslo, Norway.
Hum Mol Genet ; 31(7): 1151-1158, 2022 03 31.
Article en En | MEDLINE | ID: mdl-34788822
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Complejo Vitamínico B / Trastornos del Conocimiento / Disfunción Cognitiva Tipo de estudio: Clinical_trials Idioma: En Revista: Hum Mol Genet Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Complejo Vitamínico B / Trastornos del Conocimiento / Disfunción Cognitiva Tipo de estudio: Clinical_trials Idioma: En Revista: Hum Mol Genet Año: 2022 Tipo del documento: Article País de afiliación: China